Indevus Pharmaceuticals, Inc. (Nasdaq: IDEV) announced today that a National Institutes of Health-sponsored clinical study found that participating women who ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE